IPF patients can access clinical trials at very low to no cost. Clinical trial for interstitial lung disease are regulated research studies that seek new ways to prevent and treat “scarring” and “inflammation” of the interstitium. Prices for IPF stem cell therapy can range anywhere from $9000 - $18,000 depending on the scale and severity of the patient's condition. When researching cellular treatments for Interstitial lung disease , it is essential to understand what type of mesenchymal cells the patient will be receiving. Adult stem cells from cord-tissue sources offer high anti-inflammatory properties and lung tissue regeneration capabilities. Currently, private health insurance and medicare do not cover the cost of stem cell treatments for Interstitial lung disease but self-funded insurance policies may be used to pay for cellular therapies.